U.S. Department of Defense Invests In Prostrate Cancer Treatment

The U.S. Department of Defense/Prostrate Cancer Research Program (DoD/PCRP) gave a grant of just over $1.5 million dollars to SRI International to support pre-clinical studies of the non-profit organization’s agents that might be able to develop into drugs to treat prostate cancer. This grant follows an earlier one that had led to some positive results utilizing plant products.

The U.S. defense budget contains a great deal of novel R&D efforts and a lot of funding. Congress has used it to fund breast and other cancer and disease prevention and treatment research. Obviously the military has a great deal invested in their human capital and medical treatment and this funding helps in those areas. SRI International is a spin-off of Stanford University specializing in sponsored research for government, businesses and foundations.

Purdue Officials Report Increases in Research Funding, Technology Commercialization

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Purdue officials report double-digit increases in research funding and the number of new companies created from Purdue technologies. Richard O. Buckius, Purdue's vice president for research, reported a record $342.2 million in sponsored research programs for fiscal year 2008-09. That represents an 18 percent increase in federal support and a 2.2 percent increase in industry research support from the previous year. Joseph B. Hornett, senior vice president, t

Add to digg Add to del.icio.us Add to Newsvine Add to Reddit Add to Google Add to Yahoo My Web Email this Article

>